Prescription ID | TCMF229 |
Pinyin Name | Ba Zheng He Ji |
Chinese Name | 八正合剂 |
English Name | Ba Zheng Recipe |
Function Description | 热淋 |
Indications | Heat stranguria disorder, Acute prostatitis, Chronic prostatitis, Salmonella pyelonephritis, Chronic pyelonephritis, Cystitis, Urethritis |
Disease ICD-11 Category |
SA91 [Heat stranguria disorder (TM1), 热淋 (TM1)
]; GA91.Y [Other specified inflammatory and other diseases of prostate, 其他特指的前列腺炎性疾病 ]; GA91.0 [Chronic prostatitis, 慢性前列腺炎 ]; GC2Z [Diseases of the urinary system, unspecified, 泌尿系统疾病,未特指的 ]; GB55.Z [Chronic tubulo-interstitial nephritis, unspecified, 慢性肾小管-间质肾炎,未特指的 ]; GC00 [Cystitis, 膀胱炎 ]; GC02.Y [Other specified urethritis and urethral syndrome, 其他特指的尿道炎和尿道综合征 ]; |
Human Tissues Associated with Indication | Bladder |
Reference | Chinese pharmacopoeia (2015) |
Reference Book/link | ISBN 978-7-5067-7337-9 |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH1706 | Dianthus superbus | 瞿麦 | TCMH1706 | ITSAJ4556-14 |
TCMH241 | Plantago asiatica | 车前子 | TCMH241 | ITSAB3641-14 |
TCMH177 | Polygonum aviculare | 萹蓄 | TCMH177 | ITSAG3700-14 |
TCMH363 | Rheum officinale | 大黄 | TCMH363 | ITSAJ4685-14 |
TCMH933 | Talcum | 滑石 | TCMH933 | |
TCMH287 | Clematidis armandii caulis | 川木通 | TCMH287 | |
TCMH2641 | Gardenia jasminoides | 栀子 | TCMH2641 | ITSAJ4473-14 |
TCMH628 | Glycyrrhiza uralensis | 甘草 | TCMH628 | ITSAM892-14 |
TCMH438 | Juncus effusus | 灯心草 | TCMH438 | ITSAD4376-14 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT100 | TTR | Transthyretin | Unclassified | P02766 |
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT114 | CNR2 | Cannabinoid CB2 receptor | GPCR | P34972 |
TCMT115 | CNR1 | Cannabinoid CB1 receptor | GPCR | P21554 |
TCMT126 | TERT | Telomerase reverse transcriptase | Transferase | O14746 |
TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
TCMT128 | TNKS2 | Tankyrase-2 | Transferase | Q9H2K2 |
TCMT129 | TNKS | Tankyrase-1 | Transferase | O95271 |
TCMT13 | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | Lyase | P27695 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
TCMT151 | PRKCA | Protein kinase C alpha | Kinase | P17252 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT160 | HTR7 | Serotonin 7 (5-HT7) receptor | GPCR | P34969 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT164 | PTGS1 | Cyclooxygenase-1 | Oxidoreductase | P23219 |
TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT2 | MAPT | Microtubule-associated protein tau | Unclassified | P10636 |
TCMT207 | BACE1 | Beta-secretase 1 | Protease | P56817 |
TCMT209 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | Oxidoreductase | P80365 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT214 | MGLL | Monoglyceride lipase | Unclassified | Q99685 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT22 | ALPI | Intestinal alkaline phosphatase | Hydrolase | P09923 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT231 | GBA2 | Beta-glucosidase | Hydrolase | Q9HCG7 |
TCMT232 | ABCB1 | P-glycoprotein 1 | Transporter | P08183 |
TCMT236 | ESR2 | Estrogen receptor beta | Nuclear receptor | Q92731 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT249 | CDK6 | Cyclin-dependent kinase 6 | Kinase | Q00534 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
TCMT30 | PTGS2 | Cyclooxygenase-2 | Oxidoreductase | P35354 |
TCMT304 | MMP14 | Matrix metalloproteinase 14 | Hydrolase | P50281 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT307 | KCNH2 | HERG | Ion channel | Q12809 |
TCMT313 | HTR2B | Serotonin 2b (5-HT2b) receptor | GPCR | P41595 |
TCMT314 | HTR2C | Serotonin 2c (5-HT2c) receptor | GPCR | P28335 |
TCMT315 | HTR6 | Serotonin 6 (5-HT6) receptor | GPCR | P50406 |
TCMT318 | HKDC1 | Putative hexokinase HKDC1 | Transferase | Q2TB90 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT329 | NQO2 | Quinone reductase 2 | Oxidoreductase | P16083 |
TCMT334 | EBP | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Isomerase | Q15125 |
TCMT344 | AOX1 | Aldehyde oxidase | Oxidoreductase | Q06278 |
TCMT36 | HTR1A | Serotonin 1a (5-HT1a) receptor | GPCR | P08908 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT37 | HTR2A | Serotonin 2a (5-HT2a) receptor | GPCR | P28223 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT384 | GRK6 | G protein-coupled receptor kinase 6 | Kinase | P43250 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT434 | JAK2 | Tyrosine-protein kinase JAK2 | Kinase | O60674 |
TCMT44 | GLO1 | Glyoxalase I | Lyase | Q04760 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT45 | APP | Beta amyloid A4 protein | Unclassified | P05067 |
TCMT46 | F3 | Coagulation factor III | Unclassified | P13726 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT47 | BCL2 | Apoptosis regulator Bcl-2 | Ion channel | P10415 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT506 | PTK2B | Protein tyrosine kinase 2 beta | Kinase | Q14289 |
TCMT508 | SYK | Tyrosine-protein kinase SYK | Kinase | P43405 |
TCMT510 | KIT | Stem cell growth factor receptor | Kinase | P10721 |
TCMT558 | TOP2A | DNA topoisomerase II alpha | Isomerase | P11388 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT567 | DNMT1 | DNA (cytosine-5)-methyltransferase 1 | Transferase | P26358 |
TCMT591 | ESRRA | Estrogen-related receptor alpha | Nuclear receptor | P11474 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT599 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Transferase | P61088 |
TCMT645 | HTR1E | Serotonin 1e (5-HT1e) receptor | GPCR | P28566 |
TCMT646 | HTR5A | Serotonin 5a (5-HT5a) receptor | GPCR | P47898 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT729 | PIK3CA | PI3-kinase p110-alpha subunit | Transferase | P42336 |
TCMT730 | PIK3CB | PI3-kinase p110-beta subunit | Transferase | P42338 |
TCMT734 | MMP12 | Matrix metalloproteinase 12 | Hydrolase | P39900 |
TCMT737 | APOBEC3G | DNA dC->dU-editing enzyme APOBEC-3G | Unclassified | Q9HC16 |
TCMT740 | PIK3CG | PI3-kinase p110-gamma subunit | Transferase | P48736 |
TCMT751 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | Kinase | Q13627 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT815 | HTR1D | Serotonin 1d (5-HT1d) receptor | GPCR | P28221 |
TCMT816 | HTR1B | Serotonin 1b (5-HT1b) receptor | GPCR | P28222 |
TCMT817 | HTR4 | Serotonin 4 (5-HT4) receptor | GPCR | Q13639 |
TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT83 | CD38 | Lymphocyte differentiation antigen CD38 | Unclassified | P28907 |
TCMT881 | BBOX1 | Gamma-butyrobetaine dioxygenase | Oxidoreductase | O75936 |
TCMT910 | ESRRB | Estrogen-related receptor beta | Nuclear receptor | O95718 |
Target ID | Target Name |
---|---|
TCMT1170 | Enterobacter cloacae |
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1179 | Escherichia coli ATCC 8739 |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1182 | Streptococcus sanguinis |
TCMT1183 | Candida albicans SC5314 |
TCMT1186 | Plasmodium yoelii yoelii |
TCMT1189 | Pseudomonas fluorescens |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1198 | Serratia marcescens |
TCMT1201 | Staphylococcus epidermidis ATCC 12228 |
TCMT1207 | Legionella pneumophila |
TCMT1208 | Escherichia coli K12 |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1212 | Verticillium dahliae |
TCMT1213 | Neisseria gonorrhoeae |
TCMT1214 | Enterococcus faecium |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1218 | Staphylococcus aureus |
TCMT1219 | Enterococcus |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1224 | Proteus mirabilis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1227 | Streptococcus |
TCMT1229 | Enterococcus faecalis |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1234 | Bacillus coagulans |
TCMT1235 | Clostridium sporogenes |
TCMT1236 | Mycobacterium bovis |
TCMT1237 | Mycobacterium kansasii |
TCMT1238 | Mycobacterium xenopi |
TCMT1239 | Mycobacterium marinum |
TCMT1243 | Aspergillus flavus |
TCMT1246 | Escherichia coli |
TCMT1248 | Hepatitis C virus |
TCMT1249 | Dengue virus 2 |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1284 | Penicillium expansum |
TCMT1286 | Bacillus cereus |
TCMT1289 | Shigella dysenteriae |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1296 | Influenza A virus H3N2 |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1361 | Neisseria meningitidis |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1457 | Leishmania major |
TCMT1458 | Filobasidiella neoformans |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0007210 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 16.0056 |
[BP] GO:0098664 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 16.0056 |
[BP] GO:0042221 | response to chemical | ABCB1, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESRRA, FABP4, FLT3, HSD11B2, HSD17B2, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, JAK2, KCNH2, KDR, KIT, MMP2, MMP9, PIK3CA, PRKCA, PTGS2, RORC, SRC, TERT, TYR | 13.3493 |
[BP] GO:0065008 | regulation of biological quality | ABCB1, ACHE, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, ESR1, F3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, JAK2, KCNH2, KDR, KIT, MET, PIK3CA, PIK3CB, PRKCA, PTGS1, PTGS2, SRC, TERT, TNKS, TNKS2, XDH | 12.3497 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESRRA, HSD11B2, HSD17B2, HTR1B, HTR5A, IGF1R, JAK2, MMP2, MMP9, PIK3CA, PTGS2, RORC, SRC, TYR | 10.6124 |
[BP] GO:0010033 | response to organic substance | AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESRRA, FABP4, FLT3, HSD11B2, HSD17B2, HTR1B, HTR5A, IGF1R, JAK2, KDR, KIT, MMP2, PIK3CA, PRKCA, PTGS2, RORC, SRC, TYR | 10.2187 |
[BP] GO:0033993 | response to lipid | ALPL, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FLT3, HSD11B2, HSD17B2, HTR1B, HTR5A, JAK2, PTGS2, RORC, SRC, TYR | 10.0689 |
[BP] GO:0006629 | lipid metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EBP, ESR1, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KIT, MET, MGLL, PIK3CA, PIK3CB, PTGS1, PTGS2 | 9.64266 |
[BP] GO:0010647 | positive regulation of cell communication | AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, JAK2, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH | 9.51918 |
[BP] GO:0023056 | positive regulation of signaling | AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, JAK2, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH | 9.48911 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 8.97674 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA3, AKR1B1, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DNMT1, ESR1, ESRRA, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, JAK2, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PRKCA, PTGS1, PTGS2, SRC, TERT, XDH | 8.88079 |
[BP] GO:0010646 | regulation of cell communication | ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, ESR1, ESR2, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, JAK2, KDR, KIT, MET, MGLL, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH | 8.81642 |
[BP] GO:0023051 | regulation of signaling | ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, ESR1, ESR2, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, JAK2, KDR, KIT, MET, MGLL, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH | 8.66346 |
[BP] GO:0008152 | metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, EBP, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH | 8.60712 |
[BP] GO:0008284 | positive regulation of cell proliferation | AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, JAK2, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PRKCA, PTGS2, TERT | 8.46217 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EBP, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 8.46217 |
[BP] GO:0050896 | response to stimulus | ABCB1, ACHE, ADORA3, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESRRA, F3, FABP4, FLT3, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, JAK2, KCNH2, KDR, KIT, MGLL, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, TYR | 8.46217 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, APEX1, APP, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, HSD11B2, HTR1B, HTR5A, PTGS2, RORC, SRC, TYR | 8.36586 |
[BP] GO:0009967 | positive regulation of signal transduction | AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, JAK2, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH | 8.30554 |
[BP] GO:0043067 | regulation of programmed cell death | AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HTR2B, IGF1R, JAK2, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH | 8.27544 |
[BP] GO:0048518 | positive regulation of biological process | ABCB1, ACHE, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 8.1147 |
[BP] GO:0032501 | multicellular organismal process | AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APP, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, IGF1R, JAK2, KCNH2, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PTGS2, RORC, SRC, TNKS2, TYR | 7.96826 |
[BP] GO:0032502 | developmental process | ACHE, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, EBP, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, JAK2, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, RORC, SRC, TERT, TNKS2, TOP2A, TYR | 7.96826 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, KIT, MMP9, PTGS2, SRC, TERT | 7.93729 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, JAK2, KDR, KIT, MET, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 7.73342 |
[BP] GO:0010941 | regulation of cell death | AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HTR2B, IGF1R, JAK2, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH | 7.55736 |
[BP] GO:0042493 | response to drug | ABCB1, AKR1B1, APEX1, AXL, BCL2, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1B1, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, KCNH2, KDR, PTGS2, SRC | 7.4737 |
[BP] GO:0048584 | positive regulation of response to stimulus | AKR1B1, ALOX15, APP, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESRRA, F3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, HTR6, JAK2, KDR, KIT, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH | 7.3637 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALOX15, ALPI, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, FLT3, HTR2B, HTR2C, IGF1R, JAK2, KCNH2, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, SRC, TNKS, XDH | 7.14353 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EBP, FUT7, GBA2, GLO1, HTR2B, HTR2C, MGLL, PIK3CA, PIM1, PTGS1, PTGS2, TYR, XDH | 7.14256 |
[BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, FABP4, FLT3, HTR1B, IGF1R, KCNH2, KDR, KIT, MMP2, MMP9, PIK3CA, PTGS2, RORC, SRC, TERT | 7.12355 |
[BP] GO:0042981 | regulation of apoptotic process | AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HTR2B, IGF1R, JAK2, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH | 7.01038 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH | 6.85409 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALOX15, ALPI, CSNK2A1, CYP19A1, CYP1A1, EBP, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MGLL, PIK3CA, PIK3CB, PTGS1, PTGS2 | 6.85409 |
[BP] GO:0007198 | None | HTR1A, HTR1B, HTR5A, HTR7 | 6.83373 |
[BP] GO:0097756 | None | HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 6.82081 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALOX15, ALPI, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, FLT3, HTR2B, HTR2C, IGF1R, JAK2, KCNH2, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, SRC, TNKS, XDH | 6.73451 |
[BP] GO:1902531 | regulation of intracellular signal transduction | AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, ESR1, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, JAK2, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 6.63172 |
[BP] GO:0006468 | protein phosphorylation | APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, FLT3, HTR2B, IGF1R, JAK2, KCNH2, KDR, KIT, MET, PIK3CA, PIM1, PRKCA, SRC, TNKS | 6.57615 |
[BP] GO:0032879 | regulation of localization | ABCB1, ACHE, ADORA3, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA7, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1B1, F3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MMP12, MMP9, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT | 6.57615 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2C, JAK2, PRKCA | 6.5186 |
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.48836 |
[BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIM1, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 6.47519 |
[BP] GO:0048583 | regulation of response to stimulus | ABCB1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, JAK2, KDR, KIT, MET, MGLL, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH | 6.47519 |
[BP] GO:0043069 | negative regulation of programmed cell death | AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HTR2B, IGF1R, JAK2, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PRKCA, PTGS2, PTPN1, SRC, TERT | 6.38039 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, ESR1, ESRRA, FLT3, HSD11B2, HTR1B, HTR5A, IGF1R, KIT, MMP2, PTGS2, SRC | 6.25407 |
[BP] GO:0007165 | signal transduction | ADORA3, AKR1B1, APP, AXL, BCL2, CA1, CA2, CDK6, CNR1, CNR2, CSNK2A1, CYP1B1, DNMT1, EBP, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTPN1, RORC, SRC, TNKS, TNKS2 | 6.18922 |
[BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DNMT1, ESR1, FABP4, FLT3, HTR1B, IGF1R, KDR, KIT, MMP2, PIK3CA, PTGS2, RORC, SRC | 6.09789 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR | 6.07473 |
[BP] GO:0032844 | regulation of homeostatic process | AURKB, BCL2, CA2, CA7, CDK6, CNR1, HTR2A, HTR2B, HTR2C, KDR, PIK3CB, PTGS2, SRC, TNKS, TNKS2 | 6.06235 |
[BP] GO:0042310 | None | HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7 | 6.06235 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, APEX1, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, HTR1B, HTR1D, JAK2, KDR, SRC | 6.06164 |
[BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 6.02582 |
[BP] GO:0019369 | arachidonic acid metabolic process | ALOX15, CYP1A1, CYP1A2, CYP1B1, MGLL, PTGS1, PTGS2 | 5.92288 |
[BP] GO:0009725 | response to hormone | AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FLT3, HSD11B2, HTR1B, HTR5A, KIT, PTGS2, SRC | 5.86699 |
[BP] GO:0016310 | phosphorylation | APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, FLT3, HTR2B, IGF1R, JAK2, KCNH2, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TNKS | 5.84093 |
[BP] GO:0060548 | negative regulation of cell death | AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HTR2B, IGF1R, JAK2, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PRKCA, PTGS2, PTPN1, SRC, TERT | 5.79072 |
[BP] GO:0071704 | organic substance metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, EBP, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH | 5.62333 |
[BP] GO:0007187 | None | CNR1, CNR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 | 5.61003 |
[BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA3, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIM1, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 5.59737 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.57477 |
[BP] GO:0010604 | positive regulation of macromolecule metabolic process | ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 5.57335 |
[BP] GO:0042327 | positive regulation of phosphorylation | ALOX15, APP, BCL2, CDC25B, ESRRB, FLT3, HTR2A, HTR2B, HTR2C, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 5.53491 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA7, CA9 | 5.53301 |
[BP] GO:0040012 | regulation of locomotion | ADORA3, APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, F3, HTR1D, IGF1R, JAK2, KDR, KIT, MET, MMP9, PRKCA, PTGS2, SRC, TERT | 5.52595 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, MGLL, PTGS1, PTGS2 | 5.52595 |
[BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, FABP4, FLT3, HTR1B, IGF1R, JAK2, KCNH2, KDR, KIT, MMP2, MMP9, PIK3CA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A | 5.51673 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH | 5.49816 |
[BP] GO:0044238 | primary metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, EBP, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2B, HTR2C, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH | 5.46028 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, DYRK1A, FLT3, IGF1R, JAK2, KDR, KIT, PIM1, SRC | 5.37968 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, MGLL, PTGS1, PTGS2 | 5.31832 |
[BP] GO:2000145 | regulation of cell motility | ADORA3, APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, JAK2, KDR, KIT, MET, MMP9, PRKCA, PTGS2, SRC, TERT | 5.31832 |
[BP] GO:0001934 | positive regulation of protein phosphorylation | ALOX15, APP, BCL2, CDC25B, FLT3, HTR2A, HTR2B, HTR2C, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 5.15831 |
[BP] GO:0031325 | positive regulation of cellular metabolic process | ALOX15, APP, AURKB, BCL2, CDC25B, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 5.13243 |
[BP] GO:1903727 | positive regulation of phospholipid metabolic process | FLT3, HTR2A, HTR2B, HTR2C, KIT, SRC | 5.11875 |
[BP] GO:0043066 | negative regulation of apoptotic process | AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HTR2B, IGF1R, JAK2, KDR, MMP9, PIK3CA, PIM1, PRKCA, PTGS2, PTPN1, SRC, TERT | 5.09556 |
[BP] GO:1904707 | positive regulation of vascular smooth muscle cell proliferation | HTR1B, JAK2, MMP2, MMP9, TERT | 5.08768 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX15, ALOX5, ALPI, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP4, FUT7, GBA2, KIT, MET, MGLL, PIK3CA, PIK3CB, PTGS1, PTGS2 | 5.04921 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, FLT3, IGF1R, JAK2, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC | 5.03212 |
[BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, HTR1B, JAK2, MMP2, MMP9, PTGS2, TERT | 5.01289 |
[BP] GO:0009966 | regulation of signal transduction | AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, ESR1, ESR2, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, JAK2, KDR, KIT, MET, MGLL, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH | 5.01078 |
[BP] GO:0030334 | regulation of cell migration | ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, F3, IGF1R, JAK2, KDR, KIT, MET, MMP9, PRKCA, PTGS2, SRC, TERT | 4.9985 |
[BP] GO:0043410 | positive regulation of MAPK cascade | ALOX15, APP, FLT3, HTR2A, HTR2B, HTR2C, JAK2, KDR, KIT, PIK3CB, PRKCA, PTPN1, SRC, XDH | 4.92359 |
[BP] GO:0031401 | positive regulation of protein modification process | ALOX15, APP, BCL2, CDC25B, DNMT1, DYRK1A, FLT3, HTR2A, HTR2B, HTR2C, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 4.91101 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | ALOX15, APP, BCL2, CDC25B, ESRRB, FLT3, HTR2A, HTR2B, HTR2C, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 4.88379 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | ALOX15, APP, BCL2, CDC25B, ESRRB, FLT3, HTR2A, HTR2B, HTR2C, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 4.88379 |
[BP] GO:0009893 | positive regulation of metabolic process | ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 4.87158 |
[BP] GO:0051270 | regulation of cellular component movement | ADORA3, APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, JAK2, KDR, KIT, MET, MMP9, PRKCA, PTGS2, SRC, TERT | 4.85659 |
[BP] GO:0030335 | positive regulation of cell migration | APP, BCL2, F3, IGF1R, JAK2, KDR, KIT, MET, MMP9, PRKCA, PTGS2, SRC, TERT | 4.81252 |
[BP] GO:0042592 | homeostatic process | AKR1B1, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, CNR1, ESR1, FABP4, FLT3, HTR2A, HTR2B, HTR2C, JAK2, KCNH2, MET, PIK3CA, PIK3CB, SRC, TERT | 4.7318 |
[BP] GO:0050804 | modulation of chemical synaptic transmission | ACHE, APP, BACE1, CA2, CA7, CNR1, CNR2, HTR1B, HTR2A, KIT, PTGS2 | 4.7318 |
[BP] GO:0099177 | regulation of trans-synaptic signaling | ACHE, APP, BACE1, CA2, CA7, CNR1, CNR2, HTR1B, HTR2A, KIT, PTGS2 | 4.7318 |
[BP] GO:0051247 | positive regulation of protein metabolic process | ALOX15, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, F3, FLT3, HTR2A, HTR2B, HTR2C, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 4.68376 |
[BP] GO:2000147 | positive regulation of cell motility | APP, BCL2, F3, IGF1R, JAK2, KDR, KIT, MET, MMP9, PRKCA, PTGS2, SRC, TERT | 4.66478 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, DYRK1A, FLT3, IGF1R, JAK2, KDR, KIT, MET, SRC | 4.59152 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, DYRK1A, FLT3, IGF1R, JAK2, KDR, KIT, MET, SRC | 4.54122 |
[BP] GO:0051272 | positive regulation of cellular component movement | APP, BCL2, F3, IGF1R, JAK2, KDR, KIT, MET, MMP9, PRKCA, PTGS2, SRC, TERT | 4.54122 |
[BP] GO:0032270 | positive regulation of cellular protein metabolic process | ALOX15, APP, BCL2, CDC25B, DNMT1, DYRK1A, ESR1, F3, FLT3, HTR2A, HTR2B, HTR2C, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 4.52394 |
[BP] GO:0010038 | response to metal ion | ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, KIT, MMP9, PTGS2, TERT | 4.52394 |
[BP] GO:0007186 | G-protein coupled receptor signaling pathway | ADORA3, APP, CA2, CNR1, CNR2, ESR1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, JAK2, PIK3CA, PIK3CB, SRC | 4.52034 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EBP, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, KIT, PIK3CA, SRC, TYR | 4.44193 |
[BP] GO:0014065 | phosphatidylinositol 3-kinase signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 4.41874 |
[BP] GO:0040017 | positive regulation of locomotion | APP, BCL2, F3, IGF1R, JAK2, KDR, KIT, MET, MMP9, PRKCA, PTGS2, SRC, TERT | 4.39575 |
[BP] GO:0032228 | regulation of synaptic transmission, GABAergic | CA2, CA7, CNR1, CNR2, HTR1B | 4.3524 |
[BP] GO:0065007 | biological regulation | ABCB1, ACHE, ADORA3, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, EBP, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 4.33416 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 4.33416 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, EBP, GBA2, HTR1A, TYR | 4.31801 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX15, CYP1A1, CYP1A2, CYP1B1, MGLL, PTGS1, PTGS2 | 4.31801 |
[BP] GO:0032847 | regulation of cellular pH reduction | BCL2, CA2, CA7 | 4.30295 |
[BP] GO:0080134 | regulation of response to stress | ABCB1, APP, CDK6, CNR1, CNR2, CYP19A1, DYRK1A, ESR1, F3, FABP4, IGF1R, JAK2, MET, MGLL, MMP12, MMP2, PRKCA, PTGS2, PTPN1, SRC, TERT, XDH | 4.28308 |
[BP] GO:1901564 | organonitrogen compound metabolic process | ACHE, AKR1B1, ALPI, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, DYRK1A, ESR1, F3, FLT3, FUT7, GBA2, GLO1, HTR1A, HTR2B, HTR2C, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PRKCA, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH | 4.26447 |
[BP] GO:0051049 | regulation of transport | ABCB1, ACHE, ALOX15, APP, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, JAK2, KCNH2, MMP12, MMP9, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT | 4.26447 |
[BP] GO:0006979 | response to oxidative stress | AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, JAK2, MMP9, PTGS1, PTGS2, SRC | 4.2625 |
[BP] GO:0050795 | None | CNR1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B | 4.23373 |
[BP] GO:0019220 | regulation of phosphate metabolic process | ALOX15, APP, BCL2, CDC25B, ESRRB, FABP4, FLT3, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 4.21188 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, MGLL, PTGS1, PTGS2 | 4.18397 |
[BP] GO:0003018 | None | HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC | 4.18397 |
[BP] GO:0051174 | regulation of phosphorus metabolic process | ALOX15, APP, BCL2, CDC25B, ESRRB, FABP4, FLT3, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 4.15918 |
[BP] GO:0035690 | cellular response to drug | AKR1B1, APEX1, AXL, CDK6, CYP1B1, HTR1B, KCNH2, KDR, PTGS2, SRC | 4.13481 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 | 4.13047 |
[BP] GO:0048511 | rhythmic process | AXL, BCL2, CSNK2A1, DYRK1A, ESR1, HTR7, KIT, RORC, SRC, TOP2A | 4.11551 |
[BP] GO:0042325 | regulation of phosphorylation | ALOX15, APP, BCL2, CDC25B, ESRRB, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 4.11525 |
[BP] GO:0001932 | regulation of protein phosphorylation | ALOX15, APP, BCL2, CDC25B, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 4.11525 |
[BP] GO:0048856 | anatomical structure development | ACHE, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, EBP, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, HTR5A, JAK2, KDR, KIT, MMP9, PIK3CA, PIM1, PTGS2, RORC, SRC, TYR | 4.10645 |
[BP] GO:0043408 | regulation of MAPK cascade | ALOX15, APP, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, PIK3CB, PRKCA, PTPN1, SRC, XDH | 4.06546 |
[BP] GO:1904705 | regulation of vascular smooth muscle cell proliferation | HTR1B, JAK2, MMP2, MMP9, TERT | 3.98218 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, JAK2, MET, MMP9, PIM1, PRKCA, PTGS2, PTPN1, SRC, TNKS | 3.97807 |
[BP] GO:1903725 | regulation of phospholipid metabolic process | FLT3, HTR2A, HTR2B, HTR2C, KIT, SRC | 3.97637 |
[BP] GO:0010513 | None | HTR2A, HTR2B, HTR2C | 3.97198 |
[BP] GO:0048878 | chemical homeostasis | AKR1B1, APP, BCL2, CA12, CA2, CA7, CNR1, ESR1, FABP4, HTR2A, HTR2B, HTR2C, JAK2, KCNH2, MET, PIK3CA, PIK3CB | 3.95553 |
[BP] GO:0009987 | cellular process | ABCB1, ACHE, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, EBP, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH | 3.92437 |
[BP] GO:0007193 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 | 3.84637 |
[BP] GO:0030522 | intracellular receptor signaling pathway | ESR1, ESR2, ESRRA, ESRRB, JAK2, PIM1, RORC, SRC | 3.83497 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, APEX1, APP, AXL, CDK6, CYP1B1, DNMT1, ESR1, IGF1R, MMP2, MMP9, PIK3CA, PTGS2, RORC, SRC | 3.82455 |
[BP] GO:0008283 | cell proliferation | ABCB1, ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, HTR1A, KIT, MET, PIK3CB, PIM1, SRC, TYR | 3.82455 |
[BP] GO:0045834 | positive regulation of lipid metabolic process | FLT3, HTR2A, HTR2B, HTR2C, KIT, PTGS2, SRC | 3.79482 |
[BP] GO:0097746 | None | HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 3.7758 |
[BP] GO:0035296 | None | HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 3.7758 |
[BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CYP19A1, EBP, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.73369 |
[BP] GO:0050790 | regulation of catalytic activity | ADORA3, APP, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, JAK2, KIT, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, TNKS, XDH | 3.70955 |
[BP] GO:0048660 | regulation of smooth muscle cell proliferation | AKR1B1, HTR1B, JAK2, MMP2, MMP9, PTGS2, TERT | 3.69234 |
[BP] GO:0007167 | enzyme linked receptor protein signaling pathway | AXL, FLT3, IGF1R, JAK2, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC | 3.68957 |
[BP] GO:0043401 | steroid hormone mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, JAK2, RORC, SRC | 3.65173 |
[BP] GO:0051239 | regulation of multicellular organismal process | ADORA3, APP, AXL, BCL2, CA2, CDK6, CNR1, CYP1B1, ESR1, ESRRA, ESRRB, F3, HTR2A, HTR2B, HTR2C, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP12, MMP9, PIK3CA, PIM1, PRKCA, PTGS2, SRC, TERT, TNKS2, XDH | 3.63979 |
[BP] GO:0050880 | None | HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 3.61181 |
[BP] GO:0035150 | None | HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 3.59212 |
[BP] GO:0031399 | regulation of protein modification process | ALOX15, APP, BCL2, CDC25B, DNMT1, DYRK1A, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 3.57452 |
[BP] GO:0019222 | regulation of metabolic process | ACHE, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 3.5576 |
[BP] GO:0009892 | negative regulation of metabolic process | APEX1, APP, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, HTR1B, HTR1E, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH | 3.55294 |
[BP] GO:0031324 | negative regulation of cellular metabolic process | APEX1, APP, AURKB, BCL2, CNR1, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, HTR1B, HTR1E, HTR2B, IGF1R, MET, MMP12, MMP9, PIK3CA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH | 3.53943 |
[BP] GO:0070374 | positive regulation of ERK1 and ERK2 cascade | ALOX15, APP, HTR2A, HTR2B, HTR2C, KDR, PRKCA, SRC | 3.49755 |
[BP] GO:0010511 | None | HTR2A, HTR2B, HTR2C | 3.48965 |
[BP] GO:0051240 | positive regulation of multicellular organismal process | APP, AXL, BCL2, CA2, CNR1, CYP1B1, ESRRB, F3, HTR2A, HTR2B, JAK2, KDR, KIT, MET, MMP12, MMP9, PIM1, PRKCA, PTGS2, SRC, TERT | 3.45649 |
[BP] GO:0043271 | negative regulation of ion transport | BCL2, CNR1, HTR1B, HTR2A, KCNH2, MMP9, PTGS2 | 3.44672 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.40152 |
[BP] GO:0032845 | None | BCL2, HTR2A, HTR2B, HTR2C, SRC, TNKS, TNKS2 | 3.3902 |
[BP] GO:0070372 | regulation of ERK1 and ERK2 cascade | ALOX15, APP, HTR2A, HTR2B, HTR2C, KDR, PRKCA, PTPN1, SRC | 3.38818 |
[BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, APEX1, APP, CYP1A1, CYP1B1, ESR1, FLT3, PTGS2, RORC, SRC | 3.38818 |
[BP] GO:0003013 | None | HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC | 3.38818 |
[BP] GO:0032496 | response to lipopolysaccharide | ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, JAK2, PTGS2, SRC | 3.35398 |
[BP] GO:2000021 | regulation of ion homeostasis | BCL2, CA2, CA7, HTR2A, HTR2B, HTR2C, KDR, SRC | 3.34563 |
[BP] GO:0016477 | cell migration | AXL, CNR2, CYP1B1, FUT7, HTR2B, HTR6, JAK2, KDR, KIT, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC | 3.3444 |
[BP] GO:0051896 | regulation of protein kinase B signaling | AXL, F3, KIT, MET, PIK3CA, PIK3CB, SRC, XDH | 3.30379 |
[BP] GO:0019216 | regulation of lipid metabolic process | CNR1, CYP1A1, FLT3, HTR2A, HTR2B, HTR2C, KIT, PTGS2, RORC, SRC | 3.27207 |
[BP] GO:0051897 | positive regulation of protein kinase B signaling | AXL, F3, KIT, MET, PIK3CA, PIK3CB, SRC | 3.2552 |
[BP] GO:0050794 | regulation of cellular process | ACHE, ADORA3, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA7, CA9, CDC25B, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, EBP, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 3.20713 |
[BP] GO:0031960 | response to corticosteroid | ALPL, BCL2, FLT3, HSD11B2, HTR1B, PTGS2, SRC | 3.20713 |
[BP] GO:0048545 | response to steroid hormone | ALPL, BCL2, CA2, FLT3, HSD11B2, HTR1B, PTGS2, SRC | 3.20072 |
[BP] GO:0007188 | None | CNR1, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 | 3.19263 |
[BP] GO:0034502 | protein localization to chromosome | AURKB, ESR1, TERT, TNKS, TNKS2 | 3.18602 |
[BP] GO:0044093 | positive regulation of molecular function | ABCB1, APP, AURKB, BCL2, CDC25B, ESR1, ESR2, F3, FLT3, HTR2A, HTR2B, JAK2, KIT, MET, MMP9, PIK3CA, PIK3CB, PTPN1, SRC, TERT, TNKS, XDH | 3.18349 |
[BP] GO:0071073 | None | HTR2A, HTR2B, HTR2C | 3.16225 |
[BP] GO:0010243 | response to organonitrogen compound | AKR1B1, APEX1, APP, CNR1, CNR2, DNMT1, FLT3, HSD11B2, HTR1B, IGF1R, MMP2, PTGS2, SRC, TYR | 3.16018 |
[BP] GO:0002237 | response to molecule of bacterial origin | ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, JAK2, PTGS2, SRC | 3.15616 |
[BP] GO:0022414 | reproductive process | AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, ESR1, ESRRB, HSD11B2, HSD17B2, KIT, MMP2, MMP9, PTGS2, SRC, TOP2A | 3.13737 |
[BP] GO:0048015 | phosphatidylinositol-mediated signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 3.12838 |
[BP] GO:0099536 | None | CNR1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 | 3.12838 |
[BP] GO:0099537 | None | CNR1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 | 3.12838 |
[BP] GO:0032846 | positive regulation of homeostatic process | AURKB, CA2, CA7, CNR1, PIK3CB, PTGS2, TNKS, TNKS2 | 3.12469 |
[BP] GO:0018193 | peptidyl-amino acid modification | AURKB, AXL, BCL2, CSNK2A1, DYRK1A, FLT3, IGF1R, JAK2, KDR, KIT, MET, PRKCA, SRC, TNKS, TOP2A | 3.12469 |
[BP] GO:0006950 | response to stress | ACHE, ADORA3, AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, HSD11B2, HTR1A, HTR2C, JAK2, KIT, MGLL, MMP2, MMP9, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SRC, TERT, TOP2A | 3.12422 |
[BP] GO:0050789 | regulation of biological process | ABCB1, ACHE, ADORA3, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA7, CA9, CDC25B, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, EBP, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 3.08323 |
[BP] GO:0080090 | regulation of primary metabolic process | ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 3.08323 |
[BP] GO:0042542 | response to hydrogen peroxide | AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC | 3.08323 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC | 3.08323 |
[BP] GO:0009628 | response to abiotic stimulus | AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, HSD11B2, HTR1B, HTR2A, HTR2B, KIT, MMP2, PTGS2, SRC, TERT, TYR | 3.07942 |
[BP] GO:0007568 | aging | APEX1, AURKB, BCL2, CNR1, CYP1A1, HTR2A, PTGS2, TERT | 3.07192 |
[BP] GO:0050805 | negative regulation of synaptic transmission | ACHE, CNR2, HTR1B, HTR2A, PTGS2 | 3.04927 |
[BP] GO:0048017 | inositol lipid-mediated signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 3.04927 |
[BP] GO:2001225 | regulation of chloride transport | ABCB1, CA2, CA7 | 3.04671 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.04671 |
[BP] GO:0009755 | hormone-mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, JAK2, RORC, SRC | 3.04613 |
[BP] GO:0003008 | None | AKR1B1, APP, BCL2, CNR1, CNR2, CYP1B1, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, KCNH2, KIT, PIK3CA, PTGS2, SRC, TYR | 3.03797 |
[BP] GO:0051094 | positive regulation of developmental process | APP, AXL, BCL2, CA2, CNR1, CYP1B1, ESRRB, F3, HTR2A, HTR2C, JAK2, KDR, KIT, PIM1, PRKCA, PTGS2, SRC, TERT | 3.01858 |
[BP] GO:0002682 | regulation of immune system process | ALOX15, APP, AXL, BCL2, CA2, CDK6, CNR1, CNR2, CYP19A1, ESR1, ESRRA, JAK2, KIT, MMP12, MMP2, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC | 2.99974 |
[BP] GO:0040011 | locomotion | AXL, CNR2, CYP1B1, FUT7, HTR2B, HTR6, JAK2, KDR, KIT, MET, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC | 2.98482 |
[BP] GO:0006805 | xenobiotic metabolic process | CYP1A1, CYP1A2, CYP1B1, NQO2, PTGS1, RORC | 2.97254 |
[BP] GO:0065009 | regulation of molecular function | ABCB1, ADORA3, APP, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, ESR2, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, JAK2, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, SRC, TERT, TNKS, XDH | 2.9453 |
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC | 2.9453 |
[BP] GO:0046486 | glycerolipid metabolic process | ACHE, ALOX15, ALPI, CSNK2A1, FABP4, KIT, MET, MGLL, PIK3CA, PIK3CB | 2.94462 |
[BP] GO:0048870 | cell motility | AXL, CNR2, CYP1B1, FUT7, HTR2B, HTR6, JAK2, KDR, KIT, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC | 2.93882 |
[BP] GO:1904018 | positive regulation of vasculature development | CYP1B1, F3, KDR, KIT, PRKCA, PTGS2, TERT | 2.93412 |
[BP] GO:0002320 | lymphoid progenitor cell differentiation | BCL2, FLT3, KIT | 2.93412 |
[BP] GO:0010863 | positive regulation of phospholipase C activity | ESR1, HTR2A, HTR2B, KIT | 2.93412 |
[BP] GO:0031323 | regulation of cellular metabolic process | ACHE, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 2.89748 |
[BP] GO:0051130 | positive regulation of cellular component organization | ALOX15, APP, AURKB, AXL, BCL2, CNR1, DNMT1, ESR1, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC, TNKS, TNKS2 | 2.87795 |
[BP] GO:1901698 | response to nitrogen compound | AKR1B1, APEX1, APP, CNR1, CNR2, DNMT1, FLT3, HSD11B2, HTR1B, IGF1R, MMP2, PTGS2, SRC, TYR | 2.85166 |
[BP] GO:0043269 | regulation of ion transport | ABCB1, APP, BCL2, CA2, CA7, CNR1, HTR1A, HTR1B, HTR2A, KCNH2, MMP9, PTGS2 | 2.84587 |
[BP] GO:0048010 | vascular endothelial growth factor receptor signaling pathway | AXL, KDR, PIK3CA, PIK3CB, SRC | 2.83626 |
[BP] GO:0007208 | None | HTR2A, HTR2C | 2.80388 |
[BP] GO:0009115 | None | AOX1, XDH | 2.80388 |
[BP] GO:1900274 | regulation of phospholipase C activity | ESR1, HTR2A, HTR2B, KIT | 2.8011 |
[BP] GO:0010634 | positive regulation of epithelial cell migration | KDR, MET, MMP9, PRKCA, PTGS2, SRC | 2.77832 |
[BP] GO:0043405 | regulation of MAP kinase activity | FLT3, HTR2A, HTR2B, IGF1R, JAK2, KIT, PIK3CB, PTPN1, SRC | 2.76167 |
[BP] GO:0010810 | regulation of cell-substrate adhesion | ALOX15, BCL2, CDK6, JAK2, KDR, PIK3CB, SRC | 2.76167 |
[BP] GO:0046456 | icosanoid biosynthetic process | ALOX15, ALOX5, PTGS1, PTGS2 | 2.75909 |
[BP] GO:0002521 | leukocyte differentiation | AXL, BCL2, FLT3, FUT7, GLO1, KIT, MMP9, RORC | 2.74957 |
[BP] GO:0051098 | regulation of binding | APP, AURKB, BCL2, JAK2, MET, MMP9, SRC, TERT, TNKS | 2.73661 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.73047 |
[BP] GO:0043406 | positive regulation of MAP kinase activity | FLT3, HTR2A, HTR2B, JAK2, KIT, PIK3CB, PTPN1, SRC | 2.71953 |
[BP] GO:0046427 | positive regulation of JAK-STAT cascade | AKR1B1, CYP1B1, FLT3, JAK2, KIT | 2.71953 |
[BP] GO:0048869 | cellular developmental process | ACHE, ALPL, APP, AXL, BCL2, CDC25B, CDK6, CYP1A1, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HTR2B, JAK2, KDR, KIT, MET, MMP2, MMP9, PTGS2, RORC, SRC, TERT, TOP2A | 2.71953 |
[BP] GO:0006954 | inflammatory response | ADORA3, ALOX15, AXL, CNR2, KIT, MGLL, PIK3CA, PIK3CB, PTGS1, PTGS2 | 2.7133 |
[BP] GO:0018107 | peptidyl-threonine phosphorylation | BCL2, CSNK2A1, DYRK1A, PRKCA, TNKS | 2.69614 |
[BP] GO:1904894 | positive regulation of STAT cascade | AKR1B1, CYP1B1, FLT3, JAK2, KIT | 2.67076 |
[BP] GO:0098771 | inorganic ion homeostasis | APP, BCL2, CA12, CA2, CA7, ESR1, HTR2A, HTR2B, HTR2C, JAK2, KCNH2, PIK3CB | 2.64791 |
[BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 2.63913 |
[BP] GO:0051171 | regulation of nitrogen compound metabolic process | ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 2.56635 |
[BP] GO:0032103 | positive regulation of response to external stimulus | CNR1, F3, FABP4, JAK2, KDR, MET, PRKCA, PTGS2 | 2.56269 |
[BP] GO:0006928 | movement of cell or subcellular component | APP, AXL, CNR2, CYP1B1, FUT7, HTR2B, HTR6, JAK2, KDR, KIT, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, SRC | 2.55702 |
[BP] GO:1901989 | None | APEX1, APP, CDC25B, CYP1A1, TERT | 2.55241 |
[BP] GO:0070198 | None | TERT, TNKS, TNKS2 | 2.55241 |
[BP] GO:0043393 | regulation of protein binding | APP, AURKB, BCL2, MET, MMP9, SRC, TERT | 2.5508 |
[BP] GO:0007346 | regulation of mitotic cell cycle | APEX1, APP, AURKB, BCL2, CDC25B, CDK6, CYP1A1, PIM1, PRKCA, TERT, TNKS, TOP2A | 2.5508 |
[BP] GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | CSNK2A1, F3, JAK2, MMP9, PTGS2, SRC, XDH | 2.53886 |
[BP] GO:0006952 | defense response | ADORA3, ALOX15, APP, AXL, BCL2, CNR2, HTR1A, HTR2C, JAK2, KIT, MGLL, PIK3CA, PIK3CB, PTGS1, PTGS2, SRC | 2.53763 |
[BP] GO:0009891 | positive regulation of biosynthetic process | APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, MET, MMP12, PTGS2, RORC, SRC, TERT, TNKS, TNKS2, TOP2A | 2.53732 |
[BP] GO:0018210 | peptidyl-threonine modification | BCL2, CSNK2A1, DYRK1A, PRKCA, TNKS | 2.53731 |
[BP] GO:0035556 | intracellular signal transduction | AKR1B1, AXL, BCL2, CYP1B1, DNMT1, HTR2A, HTR2B, HTR5A, IGF1R, JAK2, KCNH2, KDR, KIT, MET, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC | 2.53694 |
[BP] GO:0051338 | regulation of transferase activity | APP, AURKB, CDC25B, FABP4, FLT3, HTR2A, HTR2B, IGF1R, JAK2, KIT, PIK3CA, PIK3CB, PTPN1, SRC, TNKS | 2.49759 |
[BP] GO:0050801 | ion homeostasis | APP, BCL2, CA12, CA2, CA7, ESR1, HTR2A, HTR2B, HTR2C, JAK2, KCNH2, PIK3CB | 2.49759 |
[BP] GO:0050999 | None | CNR1, CNR2, HTR2B, TERT | 2.49759 |
[BP] GO:2000811 | negative regulation of anoikis | BCL2, PIK3CA, SRC | 2.48603 |
[BP] GO:0071071 | None | HTR2A, HTR2B, HTR2C | 2.48603 |
[BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.48603 |
[BP] GO:0019372 | lipoxygenase pathway | ALOX15, ALOX5, PTGS2 | 2.48603 |
[BP] GO:0032101 | regulation of response to external stimulus | CNR1, CNR2, CYP19A1, ESR1, F3, FABP4, JAK2, KDR, MET, MGLL, MMP12, PRKCA, PTGS2 | 2.48603 |
[BP] GO:0045931 | positive regulation of mitotic cell cycle | APEX1, APP, CDC25B, CYP1A1, PRKCA, TERT | 2.48603 |
[BP] GO:0009056 | catabolic process | ACHE, AKR1B10, AOX1, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP4, FUT7, GBA2, MGLL, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH | 2.46939 |
[BP] GO:0045859 | regulation of protein kinase activity | APP, CDC25B, FABP4, FLT3, HTR2A, HTR2B, IGF1R, JAK2, KIT, PIK3CA, PIK3CB, PTPN1, SRC | 2.45813 |
[BP] GO:0007268 | None | HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 | 2.45813 |
[BP] GO:0098916 | None | HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 | 2.45813 |
[BP] GO:0010648 | negative regulation of cell communication | ACHE, BCL2, CNR2, DYRK1A, ESR1, ESR2, HTR1B, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH | 2.45508 |
[BP] GO:0043085 | positive regulation of catalytic activity | APP, AURKB, BCL2, CDC25B, ESR1, F3, FLT3, HTR2A, HTR2B, JAK2, KIT, PIK3CA, PIK3CB, PTPN1, SRC, TERT, TNKS, XDH | 2.44361 |
[BP] GO:0023057 | negative regulation of signaling | ACHE, BCL2, CNR2, DYRK1A, ESR1, ESR2, HTR1B, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH | 2.44361 |
[BP] GO:1903530 | regulation of secretion by cell | ACHE, CNR1, CYP19A1, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, JAK2, MMP12, PRKCA, SRC | 2.44309 |
[BP] GO:0071495 | cellular response to endogenous stimulus | AKR1B1, APEX1, APP, DNMT1, ESR1, FLT3, HTR1B, IGF1R, KIT, MMP2, PTGS2, SRC | 2.43838 |
[BP] GO:0071248 | cellular response to metal ion | ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 | 2.43838 |
[BP] GO:0051347 | positive regulation of transferase activity | AURKB, CDC25B, FLT3, HTR2A, HTR2B, JAK2, KIT, PIK3CA, PIK3CB, PTPN1, SRC, TNKS | 2.4338 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, MGLL, PTGS1, PTGS2 | 2.4338 |
[BP] GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress | BCL2, CYP1B1, JAK2 | 2.43254 |
[BP] GO:1904355 | positive regulation of telomere capping | AURKB, TNKS, TNKS2 | 2.43254 |
[BP] GO:0032787 | None | ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, GBA2, GLO1, MGLL, PTGS1, PTGS2 | 2.42825 |
[BP] GO:0038083 | peptidyl-tyrosine autophosphorylation | IGF1R, JAK2, KDR, SRC | 2.42221 |
[BP] GO:0050793 | regulation of developmental process | APP, AXL, BCL2, CA2, CDK6, CNR1, CYP1B1, ESR1, ESRRA, ESRRB, F3, HTR2A, HTR2C, JAK2, KDR, KIT, PIK3CA, PIM1, PRKCA, PTGS2, RORC, SRC, TERT, TNKS2, XDH | 2.42181 |
[BP] GO:0046110 | None | AOX1, XDH | 2.42181 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.42181 |
[BP] GO:0006939 | None | HTR1D, HTR2A, HTR2B, HTR7 | 2.39476 |
[BP] GO:0044267 | cellular protein metabolic process | ALPI, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, ESR1, FLT3, FUT7, HTR2B, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MMP1, MMP2, PIK3CA, PIM1, PRKCA, PTPN1, SRC, TNKS, TNKS2, TOP2A | 2.39435 |
[BP] GO:0016137 | None | AKR1B1, AKR1B10, GBA2 | 2.36868 |
[BP] GO:0045766 | positive regulation of angiogenesis | CYP1B1, F3, KDR, PRKCA, PTGS2, TERT | 2.36671 |
[BP] GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | BCL2, MMP9, PTGS2, PTPN1, SRC | 2.36671 |
[BP] GO:0010518 | positive regulation of phospholipase activity | ESR1, HTR2A, HTR2B, KIT | 2.36671 |
[BP] GO:0071417 | cellular response to organonitrogen compound | AKR1B1, APEX1, APP, DNMT1, HTR1B, IGF1R, MMP2, PTGS2, SRC | 2.35537 |
[BP] GO:0060255 | regulation of macromolecule metabolic process | ACHE, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH | 2.33004 |
[BP] GO:0003006 | developmental process involved in reproduction | ALPL, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, KIT, PTGS2, SRC | 2.32174 |
[BP] GO:0051900 | regulation of mitochondrial depolarization | BCL2, KDR, SRC | 2.30652 |
[BP] GO:0050730 | None | APP, FLT3, HTR2A, JAK2, KIT, PTPN1, SRC | 2.2987 |
[BP] GO:0043065 | positive regulation of apoptotic process | BCL2, CNR1, CYP1B1, F3, JAK2, MMP9, PIK3CB, PTGS2, SRC, TOP2A, XDH | 2.27546 |
[BP] GO:0022900 | electron transport chain | AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH | 2.25963 |
[BP] GO:2000116 | regulation of cysteine-type endopeptidase activity | CSNK2A1, F3, JAK2, MMP9, PTGS2, SRC, XDH | 2.24547 |
[BP] GO:0032210 | regulation of telomere maintenance via telomerase | AURKB, SRC, TNKS, TNKS2 | 2.24547 |
[BP] GO:0043068 | positive regulation of programmed cell death | BCL2, CNR1, CYP1B1, F3, JAK2, MMP9, PIK3CB, PTGS2, SRC, TOP2A, XDH | 2.24344 |
[BP] GO:0048585 | negative regulation of response to stimulus | ALOX15, BCL2, CDK6, CNR1, CNR2, CYP19A1, DYRK1A, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH | 2.24344 |
[BP] GO:0051050 | positive regulation of transport | ABCB1, ACHE, APP, AXL, BCL2, CA2, CYP19A1, HTR2B, JAK2, KCNH2, MMP12, PTGS2, SRC, TERT | 2.23013 |
[BP] GO:0018105 | peptidyl-serine phosphorylation | AURKB, BCL2, DYRK1A, PRKCA, SRC, TNKS | 2.22405 |
[BP] GO:0031328 | positive regulation of cellular biosynthetic process | APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, MET, MMP12, PTGS2, RORC, SRC, TERT, TNKS, TNKS2, TOP2A | 2.2222 |
[BP] GO:0001952 | regulation of cell-matrix adhesion | BCL2, CDK6, KDR, PIK3CB, SRC | 2.2222 |
[BP] GO:0045860 | positive regulation of protein kinase activity | CDC25B, FLT3, HTR2A, HTR2B, JAK2, KIT, PIK3CA, PIK3CB, PTPN1, SRC | 2.21503 |
[BP] GO:0043549 | regulation of kinase activity | APP, CDC25B, FABP4, FLT3, HTR2A, HTR2B, IGF1R, JAK2, KIT, PIK3CA, PIK3CB, PTPN1, SRC | 2.20253 |
[BP] GO:0048534 | hematopoietic or lymphoid organ development | BCL2, EBP, FLT3, KDR, KIT, TYR | 2.20113 |
[BP] GO:0051046 | None | ACHE, CNR1, CYP19A1, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, JAK2, MMP12, PRKCA, SRC | 2.19894 |
[BP] GO:1902532 | negative regulation of intracellular signal transduction | BCL2, DYRK1A, ESR1, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH | 2.19894 |
[BP] GO:0032768 | None | CNR1, CNR2, HTR2B, TERT | 2.19747 |
[BP] GO:0071498 | cellular response to fluid shear stress | CA2, PTGS2, SRC | 2.19658 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.19658 |
[BP] GO:0019538 | protein metabolic process | ACHE, ALPI, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, ESR1, F3, FLT3, FUT7, HTR2B, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PRKCA, PTPN1, SRC, TNKS, TNKS2, TOP2A | 2.17762 |
[BP] GO:0046686 | response to cadmium ion | CYP1A2, KIT, MMP9, TERT | 2.17419 |
[BP] GO:0055080 | cation homeostasis | APP, BCL2, CA2, CA7, ESR1, HTR2A, HTR2B, HTR2C, JAK2, KCNH2, PIK3CB | 2.17419 |
[BP] GO:0070213 | None | TNKS, TNKS2 | 2.17419 |
[BP] GO:0006145 | None | AOX1, XDH | 2.17419 |
[BP] GO:0038171 | None | CNR1, CNR2 | 2.17419 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.17419 |
[BP] GO:0014827 | None | HTR1D, HTR2B | 2.17419 |
[BP] GO:0032268 | regulation of cellular protein metabolic process | ALOX15, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 2.1646 |
[BP] GO:1901342 | regulation of vasculature development | CYP1B1, F3, KDR, KIT, PRKCA, PTGS2, TERT, XDH | 2.16353 |
[BP] GO:0071241 | cellular response to inorganic substance | ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 | 2.15239 |
[BP] GO:0030520 | intracellular estrogen receptor signaling pathway | ESR1, ESR2, SRC | 2.15118 |
[BP] GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | FLT3, HTR2A, JAK2, KIT, PTPN1, SRC | 2.14082 |
[BP] GO:1901699 | cellular response to nitrogen compound | AKR1B1, APEX1, APP, DNMT1, HTR1B, IGF1R, MMP2, PTGS2, SRC | 2.13964 |
[BP] GO:0007154 | None | AXL, BCL2, CNR1, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PTGS2 | 2.12918 |
[BP] GO:0006650 | glycerophospholipid metabolic process | ACHE, ALOX15, ALPI, CSNK2A1, KIT, MET, PIK3CA, PIK3CB | 2.12649 |
[BP] GO:0030168 | platelet activation | AXL, PIK3CA, PIK3CB, PRKCA, SRC | 2.12006 |
[BP] GO:0009991 | response to extracellular stimulus | ALPL, AXL, BCL2, CNR1, CYP1A1, HSD11B2, PTGS2, SRC, TYR | 2.11473 |
[BP] GO:0010517 | regulation of phospholipase activity | ESR1, HTR2A, HTR2B, KIT | 2.10707 |
[BP] GO:0051966 | regulation of synaptic transmission, glutamatergic | CNR1, HTR1B, HTR2A, PTGS2 | 2.10707 |
[BP] GO:2001251 | None | DNMT1, SRC, TNKS, TNKS2, TOP2A | 2.10589 |
[BP] GO:2000209 | regulation of anoikis | BCL2, PIK3CA, SRC | 2.10493 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.10493 |
[BP] GO:1904356 | regulation of telomere maintenance via telomere lengthening | AURKB, SRC, TNKS, TNKS2 | 2.08395 |
[BP] GO:0007610 | None | APP, BCL2, CNR1, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, KIT, PTGS2 | 2.08131 |
[BP] GO:0001525 | angiogenesis | CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PRKCA, PTGS2 | 2.07934 |
[BP] GO:0009611 | response to wounding | ACHE, ADORA3, ALOX15, BCL2, CYP1A1, JAK2 | 2.07727 |
[BP] GO:0044283 | None | AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, EBP, MGLL, PTGS1, PTGS2 | 2.07416 |
[BP] GO:0070301 | cellular response to hydrogen peroxide | AKR1B1, APEX1, AXL, CYP1B1 | 2.06213 |
[BP] GO:0001503 | ossification | ALOX15, ALPL, BCL2, MMP2, MMP9 | 2.06213 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1 | 2.05883 |
[BP] GO:0055082 | cellular chemical homeostasis | APP, BCL2, CA2, CA7, ESR1, HTR2A, HTR2B, HTR2C, JAK2, PIK3CA, PIK3CB | 2.05883 |
[BP] GO:0001666 | response to hypoxia | BCL2, CYP1A1, HSD11B2, MMP2, PTGS2, SRC, TERT | 2.05556 |
[BP] GO:0043412 | macromolecule modification | ALPI, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DNMT1, DYRK1A, ESR1, FLT3, FUT7, HTR2B, IGF1R, JAK2, KCNH2, KDR, KIT, MET, PIK3CA, PIM1, PRKCA, PTPN1, SRC, TNKS, TNKS2, TOP2A | 2.04727 |
[BP] GO:0033674 | positive regulation of kinase activity | CDC25B, FLT3, HTR2A, HTR2B, JAK2, KIT, PIK3CA, PIK3CB, PTPN1, SRC | 2.0411 |
[BP] GO:0060193 | positive regulation of lipase activity | ESR1, HTR2A, HTR2B, KIT | 2.0411 |
[BP] GO:0045597 | positive regulation of cell differentiation | APP, AXL, BCL2, CA2, CNR1, HTR2A, HTR2C, JAK2, KDR, KIT, PRKCA, PTGS2, TERT | 2.02435 |
[BP] GO:0018209 | peptidyl-serine modification | AURKB, BCL2, DYRK1A, PRKCA, SRC, TNKS | 2.02435 |
[BP] GO:0071902 | positive regulation of protein serine/threonine kinase activity | FLT3, HTR2A, HTR2B, JAK2, KIT, PIK3CB, PTPN1, SRC | 2.02435 |
[BP] GO:0050900 | leukocyte migration | CNR2, FUT7, KIT, MMP1, MMP9, PIK3CA, PIK3CB, SRC | 2.02435 |
[BP] GO:0046883 | regulation of hormone secretion | CNR1, CYP19A1, HTR1A, HTR2A, HTR2C, JAK2, PRKCA | 2.02331 |
[BP] GO:0010942 | positive regulation of cell death | BCL2, CNR1, CYP1B1, F3, JAK2, MMP9, PIK3CB, PTGS2, SRC, TOP2A, XDH | 2.02331 |
[BP] GO:0006464 | cellular protein modification process | ALPI, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, ESR1, FLT3, FUT7, HTR2B, IGF1R, JAK2, KCNH2, KDR, KIT, MET, PIK3CA, PIM1, PRKCA, PTPN1, SRC, TNKS, TNKS2, TOP2A | 2.01444 |
[BP] GO:0036211 | protein modification process | ALPI, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, ESR1, FLT3, FUT7, HTR2B, IGF1R, JAK2, KCNH2, KDR, KIT, MET, PIK3CA, PIM1, PRKCA, PTPN1, SRC, TNKS, TNKS2, TOP2A | 2.01444 |
[BP] GO:0045934 | None | APEX1, AURKB, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, HTR1B, HTR1E, MMP12, PRKCA, RORC, SRC, TERT, TNKS, TNKS2 | 2.00613 |
[BP] GO:0006807 | nitrogen compound metabolic process | ACHE, AKR1B1, AKR1B10, ALPI, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, FUT7, GBA2, GLO1, HTR1A, HTR2B, HTR2C, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH | 2.00613 |
[BP] GO:0046889 | None | HTR2A, HTR2B, HTR2C, PTGS2 | 2.00613 |
[BP] GO:2000573 | positive regulation of DNA biosynthetic process | AURKB, SRC, TNKS, TNKS2 | 2.00613 |
[BP] GO:0043696 | None | CDK6, ESRRB | 2.00613 |
[BP] GO:0043697 | None | CDK6, ESRRB | 2.00613 |
[BP] GO:0010641 | None | F3, SRC | 2.00613 |
[BP] GO:0071502 | None | HTR1B, HTR2B | 2.00613 |
[BP] GO:0002318 | myeloid progenitor cell differentiation | FLT3, KIT | 2.00613 |
[BP] GO:0031329 | regulation of cellular catabolic process | APEX1, BCL2, CNR1, ESRRB, HTR2A, HTR2B, KDR, MET, PIK3CA, PIK3CB, PRKCA, PTPN1 | 2.00194 |
[BP] GO:0008150 | biological_process | ABCB1, ACHE, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, EBP, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH | 2.00194 |
[CC] GO:0005886 | plasma membrane | ABCB1, ACHE, ADORA3, ALOX15, ALPI, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, ESR1, F3, FLT3, GBA2, GLO1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP2, PIK3CA, PIK3CB, PIM1, PRKCA, PTPN1, SRC, TERT | 7.53996 |
[CC] GO:0016020 | membrane | ABCB1, ACHE, ADORA3, ALOX15, ALOX5, ALPI, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EBP, ESR1, F3, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP2, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, TYR | 6.83755 |
[CC] GO:0044459 | plasma membrane part | ABCB1, ADORA3, ALOX15, APP, AXL, BACE1, CA2, CA4, CA9, CNR1, CNR2, EBP, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, JAK2, KCNH2, KDR, KIT, MET, PTGS2, SRC | 5.37968 |
[CC] GO:0031226 | intrinsic component of plasma membrane | ADORA3, APP, AXL, BACE1, CA4, CNR1, CNR2, EBP, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET | 5.37745 |
[CC] GO:0044425 | membrane part | ABCB1, ACHE, ADORA3, ALOX15, ALPI, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EBP, ESR1, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MGLL, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SRC, TYR | 5.01289 |
[CC] GO:0005887 | integral component of plasma membrane | ADORA3, APP, AXL, BACE1, CNR1, CNR2, EBP, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET | 4.52943 |
[CC] GO:0045121 | membrane raft | APP, BACE1, CNR1, HTR2A, JAK2, KDR, PTGS2, SRC | 2.45038 |
[CC] GO:0098857 | membrane microdomain | APP, BACE1, CNR1, HTR2A, JAK2, KDR, PTGS2, SRC | 2.43838 |
[CC] GO:0044432 | endoplasmic reticulum part | APP, BACE1, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EBP, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, MGLL, PTGS1, PTGS2, PTPN1 | 2.43763 |
[CC] GO:0044464 | cell part | ABCB1, ACHE, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, EBP, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH | 2.39872 |
[CC] GO:0005783 | None | APEX1, APP, BCL2, CA4, CYP19A1, EBP, FLT3, GBA2, HTR5A, KDR, PRKCA, PTGS2, PTPN1, XDH | 2.32207 |
[CC] GO:0044444 | cytoplasmic part | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APEX1, APP, AURKB, BACE1, BCL2, CA1, CA2, CA4, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EBP, ESR1, ESR2, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2A, HTR4, HTR5A, JAK2, KCNH2, KDR, KIT, MGLL, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH | 2.09222 |
[CC] GO:0098589 | membrane region | APP, BACE1, CNR1, HTR2A, JAK2, KDR, PTGS2, SRC | 2.00613 |
[MF] GO:0004993 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 16.0056 |
[MF] GO:0099589 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 16.0056 |
[MF] GO:0043176 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 16.0056 |
[MF] GO:0051378 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 16.0056 |
[MF] GO:0043167 | ion binding | ABCB1, ACHE, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, JAK2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH | 15.5911 |
[MF] GO:0046914 | transition metal ion binding | ALOX15, ALOX5, ALPI, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PRKCA, PTPN1, RORC, TNKS, TYR, XDH | 15.4584 |
[MF] GO:0099528 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 13.6738 |
[MF] GO:0003824 | catalytic activity | ABCB1, ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, EBP, F3, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH | 13.1989 |
[MF] GO:0043169 | cation binding | ACHE, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESR2, ESRRA, ESRRB, GLO1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, JAK2, KIT, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, RORC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH | 11.9885 |
[MF] GO:0008227 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 11.7099 |
[MF] GO:0042165 | neurotransmitter binding | ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 10.4295 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 9.67672 |
[MF] GO:0070405 | ammonium ion binding | ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 9.02614 |
[MF] GO:0030594 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 8.75889 |
[MF] GO:0038023 | signaling receptor activity | ADORA3, AXL, CNR1, CNR2, EBP, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, KIT, MET, RORC | 8.46217 |
[MF] GO:0008270 | zinc ion binding | ALPI, CA1, CA12, CA2, CA4, CA7, CA9, DNMT1, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PRKCA, PTPN1, RORC, TNKS | 8.36493 |
[MF] GO:0060089 | molecular transducer activity | ADORA3, AXL, CDK6, CNR1, CNR2, EBP, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, KIT, MET, RORC | 7.78258 |
[MF] GO:0004872 | receptor activity | ADORA3, AXL, CNR1, CNR2, EBP, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, KIT, MET, RORC | 7.40525 |
[MF] GO:0008144 | drug binding | ABCB1, ACHE, AURKB, AXL, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, FLT3, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TOP2A | 7.09966 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH | 6.76715 |
[MF] GO:0004871 | signal transducer activity | ADORA3, AXL, CNR1, CNR2, EBP, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, KIT, MET, RORC | 6.56021 |
[MF] GO:0016835 | carbon-oxygen lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.30054 |
[MF] GO:0046872 | metal ion binding | ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESR2, ESRRA, ESRRB, GLO1, JAK2, KIT, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, RORC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH | 6.14432 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 5.87073 |
[MF] GO:0099600 | transmembrane receptor activity | ADORA3, AXL, CNR1, CNR2, EBP, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET | 5.28871 |
[MF] GO:0004888 | transmembrane signaling receptor activity | ADORA3, AXL, CNR1, CNR2, EBP, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET | 5.28871 |
[MF] GO:0004672 | protein kinase activity | AURKB, AXL, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, JAK2, KCNH2, KDR, KIT, MET, PIK3CA, PIM1, PRKCA, SRC | 5.18069 |
[MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, JAK2, KCNH2, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC | 4.91101 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, JAK2, PTGS1, PTGS2, SRC | 4.71501 |
[MF] GO:0005496 | steroid binding | ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC | 4.69542 |
[MF] GO:0043560 | insulin receptor substrate binding | IGF1R, JAK2, PIK3CA, PIK3CB | 4.68376 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, DYRK1A, FLT3, IGF1R, JAK2, KDR, KIT, MET, SRC | 4.68267 |
[MF] GO:0016829 | lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 | 4.6283 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH | 4.54122 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, JAK2, PTGS1, PTGS2, SRC | 4.51081 |
[MF] GO:0016301 | kinase activity | AURKB, AXL, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, JAK2, KCNH2, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC | 4.44666 |
[MF] GO:0048037 | cofactor binding | AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B2, HSD17B1, JAK2, NQO2, PTGS1, PTGS2, SRC, XDH | 4.44083 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, KIT, MET | 4.30295 |
[MF] GO:0016772 | transferase activity, transferring phosphorus-containing groups | AURKB, AXL, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, JAK2, KCNH2, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TERT | 4.18397 |
[MF] GO:0042802 | identical protein binding | ACHE, AOX1, APP, BCL2, CSNK2A1, DYRK1A, ESR1, ESR2, FLT3, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP9, NQO2, PTGS2, TERT, TOP2A, TYR, XDH | 4.13481 |
[MF] GO:1901363 | heterocyclic compound binding | ABCB1, AOX1, APEX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, JAK2, KDR, KIT, MET, MMP12, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 4.12108 |
[MF] GO:0005506 | iron ion binding | ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH | 4.1049 |
[MF] GO:0097159 | organic cyclic compound binding | ABCB1, AOX1, APEX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, JAK2, KDR, KIT, MET, MMP12, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 4.02777 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, FLT3, IGF1R, KDR, KIT, MET | 3.76314 |
[MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | ESR1, ESR2, ESRRA, ESRRB, RORC | 3.53943 |
[MF] GO:0004879 | nuclear receptor activity | ESR1, ESR2, ESRRA, ESRRB, RORC | 3.53943 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.47293 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.27455 |
[MF] GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.21234 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, TYR | 3.20713 |
[MF] GO:0003707 | steroid hormone receptor activity | ESR1, ESR2, ESRRA, ESRRB, RORC | 3.18602 |
[MF] GO:0016229 | steroid dehydrogenase activity | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.11974 |
[MF] GO:0009055 | electron transfer activity | AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH | 3.08323 |
[MF] GO:0000166 | nucleotide binding | ABCB1, AOX1, AURKB, AXL, CDK6, CSNK2A1, DNMT1, DYRK1A, FLT3, HSD11B2, HSD17B1, IGF1R, JAK2, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TOP2A, XDH | 2.97743 |
[MF] GO:1901265 | nucleoside phosphate binding | ABCB1, AOX1, AURKB, AXL, CDK6, CSNK2A1, DNMT1, DYRK1A, FLT3, HSD11B2, HSD17B1, IGF1R, JAK2, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TOP2A, XDH | 2.97563 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 2.88084 |
[MF] GO:0004666 | prostaglandin-endoperoxide synthase activity | PTGS1, PTGS2 | 2.80388 |
[MF] GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | ESR1, ESR2 | 2.80388 |
[MF] GO:0003845 | None | HSD11B1, HSD11B2 | 2.80388 |
[MF] GO:0071886 | None | HTR2A, HTR2C | 2.80388 |
[MF] GO:0004930 | None | ADORA3, CNR1, CNR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 2.60741 |
[MF] GO:0016903 | None | AKR1B1, AKR1B10, AOX1, XDH | 2.49759 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 2.46939 |
[MF] GO:0042803 | protein homodimerization activity | ACHE, AOX1, BCL2, FLT3, KCNH2, KIT, MGLL, NQO2, PTGS2, TERT, TOP2A, TYR, XDH | 2.44361 |
[MF] GO:0036094 | small molecule binding | ABCB1, AOX1, AURKB, AXL, CDK6, CSNK2A1, DNMT1, DYRK1A, FABP4, FLT3, HSD11B2, HSD17B1, IGF1R, JAK2, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TOP2A, XDH | 2.43647 |
[MF] GO:0035173 | histone kinase activity | AURKB, JAK2, PRKCA | 2.43254 |
[MF] GO:0050473 | arachidonate 15-lipoxygenase activity | ALOX15, PTGS2 | 2.42181 |
[MF] GO:0004949 | None | CNR1, CNR2 | 2.42181 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR | 2.36671 |
[MF] GO:0005524 | ATP binding | ABCB1, AURKB, AXL, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, JAK2, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TOP2A | 2.28445 |
[MF] GO:0140096 | catalytic activity, acting on a protein | AURKB, AXL, BACE1, CDC25B, CDK6, CSNK2A1, DYRK1A, F3, FLT3, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PRKCA, PTPN1, SRC | 2.24344 |
[MF] GO:0032559 | adenyl ribonucleotide binding | ABCB1, AURKB, AXL, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, JAK2, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TOP2A | 2.17827 |
[MF] GO:0034056 | estrogen response element binding | ESR1, ESR2 | 2.17419 |
[MF] GO:0030554 | adenyl nucleotide binding | ABCB1, AURKB, AXL, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, JAK2, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TOP2A | 2.15552 |
[MF] GO:0043168 | anion binding | ABCB1, ALOX15, AOX1, APP, AURKB, AXL, CDK6, CSNK2A1, DYRK1A, F3, FABP4, FLT3, HSD17B1, IGF1R, JAK2, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TOP2A, XDH | 2.12006 |
[MF] GO:0030284 | estrogen receptor activity | ESR1, ESR2 | 2.00613 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Serotonergic synapse_Homo sapiens_hsa04726 | APP, HTR1E, ALOX15, HTR1D, HTR2B, HTR1A, HTR1B, HTR2C, PRKCA, HTR2A, PTGS2, HTR5A, HTR4, PTGS1, HTR6, HTR7, ALOX5 | 19.0428 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | HTR1E, HTR1D, HTR2B, HTR1A, HTR1B, HTR2C, HTR2A, HTR5A, HTR4, HTR6, HTR7, CNR2, CNR1, ADORA3 | 9.0655 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, HSD17B1, HSD17B2, CYP1A1, CYP1B1, PTGS2, CYP19A1, IGF1R | 8.7387 |
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA2, CA4, CA7, CA9, CA14 | 10.432 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD11B2, HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP19A1 | 8.2952 |
Metabolic pathways_Homo sapiens_hsa01100 | DNMT1, ALOX15, AKR1B1, PTGS2, TYR, GBA2, CYP19A1, PTGS1, HSD11B1, EBP, FUT7, AKR1B10, ALOX5, HSD17B1, HSD17B2, CYP1A2, CYP1A1, AOX1, ALPL, ALPI, XDH, MGLL | 6.5971 |
Pathways in cancer_Homo sapiens_hsa05200 | FLT3, MMP1, MMP2, PRKCA, PIK3CB, PTGS2, MMP9, IGF1R, CDK6, PIK3CA, KIT, BCL2, MET | 6.5024 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | DNMT1, CDK6, ABCB1, PIK3CA, BCL2, PIM1, CYP1B1, PRKCA, PTGS2, MMP9, MET, CDC25B | 6.763 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | PIK3CA, MMP2, BCL2, PIM1, PRKCA, PIK3CB, JAK2, F3 | 6.5421 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | PIK3CA, SRC, MMP2, KDR, PRKCA, PIK3CB, MMP9, MET, ESR1, IGF1R | 6.4915 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | PIK3CA, SRC, HTR2B, HTR2C, PRKCA, PIK3CB, HTR2A | 5.4969 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, PIK3CA, PIK3CB, PTGS2, MGLL, PTGS1 | 5.6176 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | PIK3CA, SRC, MMP2, PIK3CB, MMP9, ESR1, ESR2 | 5.4969 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | PIK3CA, SRC, CNR1, KIT, KDR, PRKCA, PIK3CB, MET, IGF1R | 5.4069 |
VEGF signaling pathway_Homo sapiens_hsa04370 | PIK3CA, SRC, KDR, PRKCA, PIK3CB, PTGS2 | 5.4969 |
Calcium signaling pathway_Homo sapiens_hsa04020 | HTR6, HTR7, HTR2B, HTR2C, PRKCA, HTR2A, HTR5A, HTR4 | 4.9278 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | CDK6, PIK3CA, KIT, KDR, BCL2, PRKCA, PIK3CB, JAK2, MET, IGF1R | 4.6651 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | PIK3CA, SRC, PIK3CB, JAK2, ESR1, ESR2 | 5.1222 |
cAMP signaling pathway_Homo sapiens_hsa04024 | HTR6, PIK3CA, HTR1E, HTR1D, HTR1A, HTR1B, PIK3CB, HTR4 | 4.6496 |
Focal adhesion_Homo sapiens_hsa04510 | PIK3CA, SRC, KDR, BCL2, PRKCA, PIK3CB, MET, IGF1R | 4.6236 |
Hepatitis B_Homo sapiens_hsa05161 | CDK6, PIK3CA, SRC, BCL2, PRKCA, PIK3CB, MMP9 | 4.5538 |
Ras signaling pathway_Homo sapiens_hsa04014 | HTR7, PIK3CA, KIT, KDR, PRKCA, PIK3CB, MET, IGF1R | 4.3102 |
Cholinergic synapse_Homo sapiens_hsa04725 | ACHE, PIK3CA, BCL2, PRKCA, PIK3CB, JAK2 | 4.1959 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | PIK3CA, FLT3, KIT, PIM1, PIK3CB | 4.4229 |
Glioma_Homo sapiens_hsa05214 | CDK6, PIK3CA, PRKCA, PIK3CB, IGF1R | 4.1952 |
Melanoma_Homo sapiens_hsa05218 | CDK6, PIK3CA, PIK3CB, MET, IGF1R | 4.0399 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | PIK3CA, FLT3, KIT, PIK3CB, MET | 4.1473 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, CSNK2A1, SRC, MET, IGF1R | 3.9678 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | PIK3CA, BCL2, PIM1, AOX1, PIK3CB, JAK2 | 3.4925 |
Small cell lung cancer_Homo sapiens_hsa05222 | CDK6, PIK3CA, BCL2, PIK3CB, PTGS2 | 3.7219 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | PIK3CA, BCL2, PRKCA, PIK3CB, IGF1R | 3.3846 |
Gap junction_Homo sapiens_hsa04540 | SRC, HTR2B, HTR2C, PRKCA, HTR2A | 3.6868 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CYP1A2, CYP1A1, CYP1B1, PTGS2 | 3.7964 |
Toxoplasmosis_Homo sapiens_hsa05145 | PIK3CA, ALOX5, BCL2, PIK3CB, JAK2 | 3.1624 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | PIK3CA, SRC, PRKCA, PIK3CB, ESR1 | 3.1624 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | PIK3CA, MMP2, PRKCA, PIK3CB, MMP9 | 3.1624 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | PIK3CA, ADORA3, BCL2, PRKCA, PIK3CB | 3.1387 |
Measles_Homo sapiens_hsa05162 | CDK6, CSNK2A1, PIK3CA, PIK3CB, JAK2 | 2.9161 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | PIK3CA, ESRRB, PIK3CB, JAK2, IGF1R | 2.8486 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | CDK6, PIK3CA, PRKCA, PIK3CB | 3.3214 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | PIK3CA, SRC, PRKCA, PIK3CB, PTGS2 | 2.6728 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | HSD11B2, PIK3CA, PRKCA, PIK3CB | 3.841 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | ALOX5, ALOX15, PTGS2, PTGS1 | 3.1624 |
Taste transduction_Homo sapiens_hsa04742 | HTR1E, HTR1D, HTR1A, HTR1B | 2.7739 |
Prostate cancer_Homo sapiens_hsa05215 | PIK3CA, BCL2, PIK3CB, IGF1R | 2.6767 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | PIK3CA, PIK3CB, CDC25B, IGF1R | 2.5367 |
ErbB signaling pathway_Homo sapiens_hsa04012 | PIK3CA, SRC, PRKCA, PIK3CB | 2.7053 |
Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, AOX1, CYP1B1 | 3.8114 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9 | 3.7964 |
TNF signaling pathway_Homo sapiens_hsa04668 | PIK3CA, PIK3CB, PTGS2, MMP9 | 2.3665 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CYP1A2, CYP1A1, CYP1B1 | 2.9492 |
Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | CNR1, PRKCA, PTGS2, MGLL | 2.4961 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | PIK3CA, SRC, PIK3CB, MET | 2.8582 |
Platelet activation_Homo sapiens_hsa04611 | PIK3CA, SRC, PIK3CB, PTGS1 | 2.2172 |
Endocytosis_Homo sapiens_hsa04144 | SRC, KIT, KDR, MET, IGF1R | 1.8681 |
Phospholipase D signaling pathway_Homo sapiens_hsa04072 | PIK3CA, KIT, PRKCA, PIK3CB | 2.022 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | PIK3CA, BCL2, PRKCA, PIK3CB | 1.9927 |
Influenza A_Homo sapiens_hsa05164 | PIK3CA, PRKCA, PIK3CB, JAK2 | 1.7625 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, IGF1R | 1.7496 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | PIK3CA, SRC, PIK3CB, JAK2 | 1.7151 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, PIK3CA, BCL2, PIK3CB | 1.6326 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2, PRKCA | 1.759 |
Viral carcinogenesis_Homo sapiens_hsa05203 | CDK6, PIK3CA, SRC, PIK3CB | 1.6211 |
Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | PIK3CA, PRKCA, PIK3CB | 1.7508 |
Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | PIK3CA, PRKCA, PIK3CB | 2.0614 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | CDK6, PIK3CA, PIK3CB | 1.9927 |
mTOR signaling pathway_Homo sapiens_hsa04150 | PIK3CA, PRKCA, PIK3CB | 2.1735 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | PIK3CA, PIK3CB, IGF1R | 2.1081 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | PIK3CA, PIK3CB, IGF1R | 1.7496 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.2698 |
Pancreatic cancer_Homo sapiens_hsa05212 | CDK6, PIK3CA, PIK3CB | 2.0913 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | BCL2 | 0.2791 |
Melanogenesis_Homo sapiens_hsa04916 | KIT, PRKCA, TYR | 1.7036 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, BCL2, PTGS2 | 1.7508 |
Colorectal cancer_Homo sapiens_hsa05210 | PIK3CA, BCL2, PIK3CB | 2.1401 |
Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | PIK3CA, PRKCA, PIK3CB | 1.7151 |
Renal cell carcinoma_Homo sapiens_hsa05211 | PIK3CA, PIK3CB, MET | 2.0913 |
Amoebiasis_Homo sapiens_hsa05146 | PIK3CA, PRKCA, PIK3CB | 1.7036 |
Choline metabolism in cancer_Homo sapiens_hsa05231 | PIK3CA, PRKCA, PIK3CB | 1.697 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, PIK3CA, PIK3CB | 1.628 |
Neurotrophin signaling pathway_Homo sapiens_hsa04722 | PIK3CA, BCL2, PIK3CB | 1.5262 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KIT, KDR, MET | 1.3207 |
AMPK signaling pathway_Homo sapiens_hsa04152 | PIK3CA, PIK3CB, IGF1R | 1.4981 |
FoxO signaling pathway_Homo sapiens_hsa04068 | PIK3CA, PIK3CB, IGF1R | 1.4323 |
Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | PIK3CA, PRKCA, PIK3CB | 1.42 |
Apoptosis_Homo sapiens_hsa04210 | PIK3CA, BCL2, PIK3CB | 1.3969 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP1A2, CYP1A1, AOX1 | 2.0962 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1, MGLL | 2.1868 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.3627 |
Dopaminergic synapse_Homo sapiens_hsa04728 | PRKCA | 0.3602 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.3706 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1, PIK3CA, PIK3CB | 1.4004 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC, PRKCA | 1.4004 |
Vascular smooth muscle contraction_Homo sapiens_hsa04270 | PRKCA | 0.3761 |
MAPK signaling pathway_Homo sapiens_hsa04010 | PRKCA, CDC25B | 0.479 |
Glutamatergic synapse_Homo sapiens_hsa04724 | PRKCA | 0.3906 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | PIK3CA, SRC, PIK3CB | 1.0076 |
HTLV-I infection_Homo sapiens_hsa05166 | PIK3CA, TERT, PIK3CB | 0.8459 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | PIK3CA, ADORA3, PIK3CB | 1.2311 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1, JAK2 | 0.6377 |
Alzheimer's disease_Homo sapiens_hsa05010 | BACE1, APP | 0.6805 |
Tuberculosis_Homo sapiens_hsa05152 | SRC, BCL2, JAK2 | 1.1861 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PIK3CA, PIK3CB | 0.744 |
Wnt signaling pathway_Homo sapiens_hsa04310 | CSNK2A1, PRKCA | 0.7804 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.4508 |
Osteoclast differentiation_Homo sapiens_hsa04380 | PIK3CA, PIK3CB | 0.8153 |
Hepatitis C_Homo sapiens_hsa05160 | PIK3CA, PIK3CB | 0.8133 |
Cell cycle_Homo sapiens_hsa04110 | CDK6, CDC25B | 0.8465 |
Circadian entrainment_Homo sapiens_hsa04713 | PRKCA | 0.4508 |
Morphine addiction_Homo sapiens_hsa05032 | PRKCA | 0.4605 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1 | 0.4618 |
Salivary secretion_Homo sapiens_hsa04970 | PRKCA | 0.4631 |
Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | PIK3CA, PIK3CB | 0.9547 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.4631 |
Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | PIK3CA, PIK3CB | 0.9646 |
Insulin secretion_Homo sapiens_hsa04911 | PRKCA | 0.474 |
T cell receptor signaling pathway_Homo sapiens_hsa04660 | PIK3CA, PIK3CB | 0.9646 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.479 |
Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | PRKCA | 0.4831 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2, PRKCA | 1.0109 |
Complement and coagulation cascades_Homo sapiens_hsa04610 | F3 | 0.4895 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | JAK2 | 0.5283 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3, KIT | 1.0735 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC, PRKCA | 1.0735 |
Thyroid hormone synthesis_Homo sapiens_hsa04918 | PRKCA | 0.5258 |
p53 signaling pathway_Homo sapiens_hsa04115 | CDK6 | 0.5308 |
Long-term potentiation_Homo sapiens_hsa04720 | PRKCA | 0.5415 |
Amphetamine addiction_Homo sapiens_hsa05031 | PRKCA | 0.5388 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.5444 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | RORC | 0.5444 |
B cell receptor signaling pathway_Homo sapiens_hsa04662 | PIK3CA, PIK3CB | 1.2033 |
Leishmaniasis_Homo sapiens_hsa05140 | PTGS2, JAK2 | 1.2033 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2, PRKCA | 1.1965 |
Inositol phosphate metabolism_Homo sapiens_hsa00562 | PIK3CA, PIK3CB | 1.2172 |
Bile secretion_Homo sapiens_hsa04976 | ABCB1, CA2 | 1.2172 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP4, MMP1 | 1.2311 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP1A2, AOX1 | 1.2311 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET | 1.2311 |
Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | PRKCA | 0.6021 |
Long-term depression_Homo sapiens_hsa04730 | PRKCA, IGF1R | 1.3222 |
Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | BCL2 | 0.6282 |
Vibrio cholerae infection_Homo sapiens_hsa05110 | PRKCA | 0.6282 |
Malaria_Homo sapiens_hsa05144 | MET | 0.6377 |
Endometrial cancer_Homo sapiens_hsa05213 | PIK3CA, PIK3CB | 1.4159 |
Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | AOX1 | 0.6398 |
Sphingolipid metabolism_Homo sapiens_hsa00600 | GBA2 | 0.6449 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | XDH | 0.6501 |
ABC transporters_Homo sapiens_hsa02010 | ABCB1 | 0.6613 |
Cysteine and methionine metabolism_Homo sapiens_hsa00270 | DNMT1 | 0.6556 |
Type II diabetes mellitus_Homo sapiens_hsa04930 | PIK3CA, PIK3CB | 1.4675 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | PRKCA, ESR1 | 1.48 |
Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | PIK3CA, PIK3CB | 1.5063 |
Pyruvate metabolism_Homo sapiens_hsa00620 | GLO1 | 0.6927 |
African trypanosomiasis_Homo sapiens_hsa05143 | PRKCA | 0.743 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.7542 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.7804 |
Base excision repair_Homo sapiens_hsa03410 | APEX1 | 0.7602 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2 | 1.7647 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.7284 |
Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | AOX1 | 0.7991 |
Tyrosine metabolism_Homo sapiens_hsa00350 | AOX1, TYR | 1.6853 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.83 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.6668 |
Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.7889 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.8182 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.9504 |
Steroid biosynthesis_Homo sapiens_hsa00100 | EBP | 0.9278 |
Other glycan degradation_Homo sapiens_hsa00511 | GBA2 | 0.9646 |
Folate biosynthesis_Homo sapiens_hsa00790 | ALPL, ALPI | 2.2911 |
Vitamin B6 metabolism_Homo sapiens_hsa00750 | AOX1 | 1.3551 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP1A2, XDH | 3.1322 |